Akero Therapeutics, Inc.盘中异动早盘股价大涨5.24%报41.94美元

市场透视2025-05-12

北京时间2025年05月12日21时40分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报41.94美元/股，成交量3.3805万股，换手率0.04%，振幅4.48%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.16倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2534511279?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-12 21:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2534511279","market":"us","top_or_hot":-1,"title":"Akero Therapeutics, Inc.盘中异动 早盘股价大涨5.24%报41.94美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月12日21时40分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报41.94美元/股，成交量3.3805万股，换手率0.04%，振幅4.48%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.16倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214023975745de&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akero Therapeutics, Inc.盘中异动 早盘股价大涨5.24%报41.94美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkero Therapeutics, Inc.盘中异动 早盘股价大涨5.24%报41.94美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-12 21:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214023975745de&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月12日21时40分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报41.94美元/股，成交量3.3805万股，换手率0.04%，振幅4.48%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.16倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214023975745de&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214023975745de&s=b","article_id":"2534511279","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512214023975745de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2534511279","pubTimestamp":1747057211,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月12日21时40分，Akero Therapeutics, Inc.股票出现异动，股价快速拉升5.24%。Akero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.71%。Akero Therapeutics, Inc.公司简介：Akero Therapeutics Inc是一家临床阶段的生物技术公司，致力于开发和商业化针对医疗需求高度未得到满足的严重代谢疾病的变革性治疗。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","BK4539":"次新股","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","AKRO":"Akero Therapeutics","BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Akero Therapeutics, Inc. shares jumped 5.24% to $41.94 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"AKRO":1},"content_text":"北京时间2025年05月12日21时40分，Akero Therapeutics, Inc.（AKRO.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报41.94美元/股，成交量3.3805万股，换手率0.04%，振幅4.48%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.52亿美元，每股收益-3.75美元，毛利-18000.00美元，市盈率-11.16倍。机构评级方面，在所有11家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Akero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.71%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、艾吉纳斯涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为358.99%、74.61%、59.59%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、艾吉纳斯、奥麦罗制药，振幅分别为49.55%、29.55%、23.46%。Akero Therapeutics, Inc.公司简介：Akero Therapeutics Inc是一家临床阶段的生物技术公司，致力于开发和商业化针对医疗需求高度未得到满足的严重代谢疾病的变革性治疗。它专注于非酒精性脂肪性肝炎(NASH)，一种没有任何批准疗法的疾病。该公司的候选产品efruxifermin是一种FGF21类似物，其特性有可能解决非酒精性脂肪性肝炎(NASH)发病机制的核心过程。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2534511279","isCrawlerRequest":true}

Akero Therapeutics, Inc.盘中异动 早盘股价大涨5.24%报41.94美元

精彩评论

Akero Therapeutics, Inc.盘中异动早盘股价大涨5.24%报41.94美元